Tandem Repeat Modification during Double-Strand Break Repair Induced by an Engineered TAL Effector Nuclease in Zebrafish Genome. Huang W, Zheng J, He Y, Luo, PLoS ONE 8(12): e84176. doi:10.1371/journal.pone.0084176
FULL TEXT PDF
Friday, December 27, 2013
Dysphagia and swallowing-related quality of life in Friedreich ataxia
Dysphagia and swallowing-related quality of life in Friedreich ataxia. Adam P. Vogel, Sophie E. Brown, Joanne E. Folker, Louise A. Corben, Martin B. Delatycki;
Journal of Neurology, December 2013. DOI 10.1007/s00415-013-7208-4
Keywords: Dysphagia, Friedreich ataxia (FRDA), quality of life, oral-motor examination, speech and swallowing, incoordination, weakness, spasticity.
Journal of Neurology, December 2013. DOI 10.1007/s00415-013-7208-4
Keywords: Dysphagia, Friedreich ataxia (FRDA), quality of life, oral-motor examination, speech and swallowing, incoordination, weakness, spasticity.
Role of Frataxin, a Protein Implicated in Friedreich Ataxia, in Making Iron-Sulfur Clusters
Role of Frataxin, a Protein Implicated in Friedreich Ataxia, in Making Iron-Sulfur Clusters. The Journal of Biological Chemistry, 288, 36787. December 27, 2013; 10.1074/jbc.P113.525857
The authors concluded that their work “may help develop a drug for treating Friedreich ataxia associated with frataxin deficiency.”
See referenced article: Frataxin Directly Stimulates Mitochondrial Cysteine Desulfurase by Exposing Substrate-binding Sites, and a Mutant Fe-S Cluster Scaffold Protein with Frataxin-bypassing Ability Acts Similarly. J. Biol. Chem. 2013, 288, 36773–36786.
The authors concluded that their work “may help develop a drug for treating Friedreich ataxia associated with frataxin deficiency.”
See referenced article: Frataxin Directly Stimulates Mitochondrial Cysteine Desulfurase by Exposing Substrate-binding Sites, and a Mutant Fe-S Cluster Scaffold Protein with Frataxin-bypassing Ability Acts Similarly. J. Biol. Chem. 2013, 288, 36773–36786.
Friday, December 20, 2013
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring
Common defects of mitochondria and iron in neurodegeneration and diabetes (MIND): A paradigm worth exploring; Matthew Stroh, Russell H. Swerdlow, Hao Zhu; Biochemical Pharmacology, Available online 19 December 2013.
Thursday, December 19, 2013
Erythropoietin and the heart: Physiological effects and the therapeutic perspective
Erythropoietin and the heart: Physiological effects and the therapeutic perspective. Fabian Sanchis-Gomar, José Luis Garcia-Gimenez, Helios Pareja-Galeano, Marco Romagnoli, Carme Perez-Quilis, Giuseppe Lippi; International Journal of Cardiology, Available online 18 December 2013, http://dx.doi.org/10.1016/j.ijcard.2013.12.011
Keywords: Myocardial infarction; cardioprotection; remodelling; EpoR; angiogenesis; apoptosis; inflammation; pleiotropic actions; Friedreich’s ataxia
If rhEpo or its analogues improve(s) the muscle and mitochondrial function it would help improve the cardiac function. However, none of these studies and clinical trials mentioned the long-term effect of rhEpo on the heart of FRDA. Thus, an effort designing a clinical trial involving treatments a long term in FRDA patients are strongly recommended.
Keywords: Myocardial infarction; cardioprotection; remodelling; EpoR; angiogenesis; apoptosis; inflammation; pleiotropic actions; Friedreich’s ataxia
If rhEpo or its analogues improve(s) the muscle and mitochondrial function it would help improve the cardiac function. However, none of these studies and clinical trials mentioned the long-term effect of rhEpo on the heart of FRDA. Thus, an effort designing a clinical trial involving treatments a long term in FRDA patients are strongly recommended.
Wednesday, December 18, 2013
The role of iron and reactive oxygen species in cell death
The role of iron and reactive oxygen species in cell death. Scott J Dixon & Brent R Stockwell; Nature Chemical Biology, 10, 9–17(2014), doi:10.1038/nchembio.1416; Published online 17 December 2013
Keywords: iron, potentially toxic iron-catalyzed reactive oxygen species (ROS), cell death, ferroptosis, cancer, organ damage,degenerative disease.
Keywords: iron, potentially toxic iron-catalyzed reactive oxygen species (ROS), cell death, ferroptosis, cancer, organ damage,degenerative disease.
Sunday, December 15, 2013
Vitamin E is essential for Purkinje neuron integrity
Vitamin E is essential for Purkinje neuron integrity. L. Ulatowski, R. Parker, G. Warrier, R. Sultana, D.A. Butterfield, D. Manor; Neuroscience, Available online 14 December 2013. http://dx.doi.org/10.1016/j.neuroscience.2013.12.001
Keywords: Vitamin E; Tocopherol; Purkinje neuron; Cerebellum; Ataxia; Oxidative stress
Keywords: Vitamin E; Tocopherol; Purkinje neuron; Cerebellum; Ataxia; Oxidative stress
Wednesday, December 11, 2013
Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells
Modeling of Friedreich ataxia-related iron overloading cardiomyopathy using patient-specific-induced pluripotent stem cells. Yee-Ki Lee, Philip Wing-Lok Ho, Revital Schick, Yee-Man Lau, Wing-Hon Lai, Ting Zhou, Yanhua Li, Kwong-Man Ng, Shu-Leung HO, Miguel Angel Esteban,
Ofer Binah, Hung-Fat Tse, Chung-Wah Siu; Pflügers Archiv - European Journal of Physiology, December 2013
Keywords: Friedreich ataxia (FRDA), hypertrophic cardiomyopathy, frataxin, FRDA-cardiac cellular models, iron homeostasis, calcium homeostasis, contractile force.
Ofer Binah, Hung-Fat Tse, Chung-Wah Siu; Pflügers Archiv - European Journal of Physiology, December 2013
Keywords: Friedreich ataxia (FRDA), hypertrophic cardiomyopathy, frataxin, FRDA-cardiac cellular models, iron homeostasis, calcium homeostasis, contractile force.
REGIONAL SIDEROSIS: A NEW CHALLENGE FOR IRON CHELATION THERAPY
REGIONAL SIDEROSIS: A NEW CHALLENGE FOR IRON CHELATION THERAPY. Cabantchik Zvi Ioav, Munnich Arnold, Youdim Moussa B., Devos David; Frontiers in Pharmacology, Paper pending published: 09 Dec 2013
Keywords: Iron, chelation, neurodegeneration, Anemia, Friedreich Ataxia, Parkinson Disease, deferiprone
Keywords: Iron, chelation, neurodegeneration, Anemia, Friedreich Ataxia, Parkinson Disease, deferiprone
Saturday, December 7, 2013
Italy blocks controversial stem cell therapy
Italy blocks controversial stem cell therapy. Nature Biotechnology 31, 1062 (2013); doi:10.1038/nbt1213-1062a
Published online 06 December 2013
The Italian government withdrew its support for a controversial stem cell therapy trial before it was due to start, prompting an outcry from patients. The decision was announced by Health Minister Beatrice Lorenzin on October 10, after an ad hoc scientific committee deemed the treatment too risky and undefined. In…
Published online 06 December 2013
The Italian government withdrew its support for a controversial stem cell therapy trial before it was due to start, prompting an outcry from patients. The decision was announced by Health Minister Beatrice Lorenzin on October 10, after an ad hoc scientific committee deemed the treatment too risky and undefined. In…
Subscribe to:
Posts (Atom)
